| P2093 | author name string | A Kaladjian | |
| | D Dassa | |
| | D Pringuey | |
| | E Fakra | |
| | J-M Azorin | |
| | M Cermolacce | |
| | M Dubois | |
| | M Maurel | |
| | R Belzeaux | |
| P2860 | cites work | Lithium-induced increase in human brain grey matter | Q73176044 |
| | Clinical predictors of acute response with quetiapine in psychotic mood disorders | Q73805999 |
| | Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate | Q74171173 |
| | Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder | Q77720351 |
| | [Mixed states in bipolar disorders: a review of current therapeutic strategies] | Q83107883 |
| | Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication | Q33462011 |
| | The efficacy of ECT in mixed affective states | Q33874091 |
| | Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses | Q34292519 |
| | Number of prior episodes and the presence of depressive symptoms are associated with longer length of stay for patients with acute manic episodes | Q35854309 |
| | Pharmacotherapy of bipolar mixed states | Q36130303 |
| | Electroconvulsive therapy in the treatment of mixed states in bipolar disorder | Q37055707 |
| | Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium | Q37524501 |
| | Valproate and neuroprotective effects for bipolar disorder | Q37726041 |
| | Efficacy of antimanic treatments in mixed states | Q38003197 |
| | Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study | Q38378764 |
| | A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes | Q42627987 |
| | A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states | Q43258938 |
| | Asenapine versus olanzapine in acute mania: a double-blind extension study | Q43260786 |
| | Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 |
| | Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 |
| | Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes: a naturalistic study | Q43876547 |
| | Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania | Q43942949 |
| | Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 |
| | Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study | Q44159999 |
| | A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania | Q44168457 |
| | Quetiapine in the treatment of rapid cycling bipolar disorder. | Q44247110 |
| | Acute dysphoric mania: treatment response to olanzapine versus placebo | Q44364152 |
| | Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients | Q44710965 |
| | A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. | Q44877765 |
| | A double-blind comparison of valproate and lithium in the treatment of acute mania | Q44975667 |
| | Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy | Q46096383 |
| | Prevalence of mixed mania using 3 definitions | Q46120264 |
| | Differences in incidence of suicide attempts during phases of bipolar I and II disorders | Q46562272 |
| | Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial | Q46683979 |
| | Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder | Q46975571 |
| | Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes | Q48354512 |
| | Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients | Q48886105 |
| | Depression during mania. Treatment response to lithium or divalproex. | Q50978467 |
| | Clinical predictors of functional outcome of bipolar patients in remission. | Q53102303 |
| | The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. | Q53260493 |
| | ECT in mixed affective states: a case series. | Q54046952 |
| | Electroconvulsive Therapy in Medication-Nonresponsive Patients With Mixed Mania and Bipolar Depression | Q60633566 |
| | Clozapine in the treatment of dysphoric mania | Q67571510 |
| | Differences and similarities in mixed and pure mania | Q71993596 |
| P304 | page(s) | S172-8 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | L'Encephale: revue de psychiatrie clinique biologique et therapeutique | Q3202945 |
| P1476 | title | Antimanic treatments in bipolar mixed states | |
| P478 | volume | 39 Suppl 3 | |